News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
January 19, 2021
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.
![1]()
News
CVD deaths rose, imaging declined during pandemic
January 14, 2021
Two new papers quantify the impact of COVID-19 on patients with heart disease: more deaths, less disease testing or diagnosis. Experts suggest shutdowns may have been too complete.
![1]()
News
A standardized approach to postop management of DOACs in AFib
January 13, 2021
Is it safe to adopt a standardized approach to direct oral anticoagulant (DOAC) interruption for patients with atrial fibrillation (AFib) who are undergoing elective surgeries/procedures?
![1]()
News
Calcium-induced autonomic denervation linked to lower post-op AF
January 13, 2021
Although targeting the four major atrial ganglionated plexi reduced post-CABG atrial fibrillation, it’s not clear whether it can prevent stroke.
News
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
January 12, 2021
Trials are urgently needed to define optimal anticoagulation strategies for COVID-19 infection.
![1]()
News
Updated ACC decision pathway embraces new heart failure treatment strategies
January 11, 2021
The ACC’s updated decision pathway aims to close the substantial gap between current practice and unmet opportunities for inhibiting HFrEF progression.
![1]()
News
COVID-19 mortality in hospitalized HF patients: Nearly 1 in 4
December 31, 2020
In-hospital mortality was 24.2% for patients with HF hospitalized with COVID-19, as compared with 14.2% for individuals without HF who were hospitalized with COVID-19.
News
NETs a possible therapeutic target for COVID-19 thrombosis?
December 31, 2020
Small study, but may provide insight regarding COVID-19 patients who experience acute STEMI.
![1]()
News
ACC/AHA update two atrial fibrillation performance measures
December 14, 2020
The changes clarify the definition of atrial fibrillation and separate CHA2DS2-VASc risk score treatment thresholds for men and women; both are in line with 2019 guideline changes.
![1]()
News
Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess
December 10, 2020
Is there significant change in the tumor size or hormonal function of benign nonfunctioning adrenal tumors (NFATs) or adenomas causing mild autonomous cortisol excess (MACE) over time?
